Related Experiment Video
Updated: Jan 21, 2026
06:04
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
1.4K
Adiponectin: An Indicator for Metabolic Syndrome
Somaye Yosaee1,2, Mahmoud Khodadost3,4, Alireza Esteghamati5
1Department of Nutrition, School of Health, Larestan University of Medical Sciences, Larestan, Iran.
Iranian Journal of Public Health
|July 26, 2019
Summary
Metabolic syndrome (MetS) is linked to obesity, but not all obese individuals develop it. This study found lower adiponectin and higher leptin levels in metabolically unhealthy obese patients, indicating their potential as biomarkers for MetS.
Area of Science:
- Endocrinology
- Metabolic Health
- Obesity Research
Background:
- Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors often associated with obesity.
- A subset of obese individuals do not develop MetS, suggesting other contributing factors.
- Understanding differences between metabolically unhealthy obese (MUO) and metabolically healthy obese (MHO) individuals is crucial.
Purpose of the Study:
- To investigate differences in plasma adiponectin and leptin concentrations between MUO patients and matched controls.
- To identify potential biomarkers differentiating obese individuals with and without MetS.
Main Methods:
- A case-control study involving 51 MUO patients and 102 controls (MHO and normal weight metabolic healthy subjects).
- Subjects were matched for age and gender.
- Serum adiponectin, leptin, their ratio, and body composition were measured.
Main Results:
- MUO subjects exhibited significantly lower plasma adiponectin levels compared to MHO and normal weight controls.
- Plasma leptin levels were significantly higher in MUO subjects.
- The adiponectin to leptin ratio was significantly lower in MUO individuals.
- Adiponectin and leptin levels demonstrated predictive ability for MetS, with AUCs of 0.73 and 0.66, respectively.
Conclusions:
- Adiponectin and leptin levels serve as indicators for distinguishing metabolically unhealthy obesity.
- These adipokines may be valuable biomarkers for identifying individuals at risk of developing MetS.
- Further research can explore therapeutic interventions targeting these adipokines.
More Related Videos
Related Concept Videos
02:39Indicators
59.7K
Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
59.7K
00:52What is Metabolism?
131.2K
Overview
131.2K
01:29Mechanical Ventilation I: Indication and Settings
2.7K
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.7K
01:19Respiratory Assessment: Purpose and Indications
1.7K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.7K
01:24Nephrotic Syndrome I : Introduction
522
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
522
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
154
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
154